Nanalysis Scientific Corp.
NSCI.V
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 7.67M | 7.66M | 6.74M | 6.92M | 7.38M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.67M | 7.66M | 6.74M | 6.92M | 7.38M |
| Cost of Revenue | 5.95M | 5.58M | 5.27M | 5.24M | 5.49M |
| Gross Profit | 1.72M | 2.08M | 1.47M | 1.68M | 1.89M |
| SG&A Expenses | 1.58M | 1.44M | 1.66M | 2.20M | 1.94M |
| Depreciation & Amortization | 607.60K | 367.30K | 602.60K | 713.40K | 598.50K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.30M | 7.43M | 7.59M | 8.25M | 8.12M |
| Operating Income | -629.20K | 223.80K | -850.90K | -1.33M | -742.10K |
| Income Before Tax | -893.10K | -534.40K | -1.08M | -1.56M | -873.80K |
| Income Tax Expenses | 28.00K | -11.50K | 11.60K | -24.60K | 36.90K |
| Earnings from Continuing Operations | -921.20K | -522.90K | -1.09M | -1.53M | -910.70K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -921.20K | -522.90K | -1.09M | -1.53M | -910.70K |
| EBIT | -629.20K | 223.80K | -850.90K | -1.33M | -742.10K |
| EBITDA | -522.10K | 332.80K | -753.60K | -1.19M | -98.20K |
| EPS Basic | -0.01 | 0.00 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | -0.01 | -0.01 | 0.00 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | -0.01 | -0.01 | 0.00 |
| Average Basic Shares Outstanding | 136.88M | 117.22M | 114.82M | 113.54M | 113.22M |
| Average Diluted Shares Outstanding | 136.88M | 117.22M | 114.82M | 113.54M | 113.22M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |